Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Long-Term Deferred Tax (2022 - 2023)

Historic Long-Term Deferred Tax for 60 Degrees Pharmaceuticals (SXTP) over the last 2 years, with Q4 2023 value amounting to $3.7 million.

  • 60 Degrees Pharmaceuticals' Long-Term Deferred Tax rose 1207.47% to $3.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.7 million, marking a year-over-year increase of 1207.47%. This contributed to the annual value of $3.7 million for FY2023, which is 1207.47% up from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Long-Term Deferred Tax of $3.7 million as of Q4 2023, which was up 1207.47% from $1.0 million recorded in Q2 2023.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Long-Term Deferred Tax peaked at $3.7 million during Q4 2023, and registered a low of $1.0 million during Q2 2023.